Short general description of Flibanserin Flibanserin is a medication that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Flibanserin, also known by its brand name Addyi, is the first and only FDA-approved treatment for HSDD. HSDD is a condition characterized by a persistent lack of sexual desire that causes personal distress. It is estimated to impact approximately 1 in 10 women. This medication works by…
Short general description of Flibanserin Flibanserin, also known by its brand name Addyi, is a medication approved by the FDA for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by restoring the balance of certain neurotransmitters in the brain, particularly serotonin and dopamine, which are involved in regulating sexual desire. Flibanserin is not a hormone-based treatment and is taken daily to address persistent low libido in women. The Importance of Flibanserin for Women’s Health Women’s…